SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 215 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $154 | -75.8% | 14,209 | -58.2% | 0.02% | -75.0% |
| Q1 2024 | $637 | +13.8% | 33,983 | +31.4% | 0.07% | +15.3% |
| Q4 2023 | $560 | +7.1% | 25,861 | +132.6% | 0.06% | -10.6% |
| Q2 2023 | $523 | -16.2% | 11,120 | -25.2% | 0.07% | +13.8% |
| Q1 2023 | $624 | -99.9% | 14,876 | -10.8% | 0.06% | -4.9% |
| Q2 2022 | $539,000 | +54.4% | 16,680 | +258.1% | 0.06% | +56.4% |
| Q1 2021 | $349,000 | +4.5% | 4,658 | -60.0% | 0.04% | -40.0% |
| Q1 2020 | $334,000 | +7.1% | 11,646 | +424.1% | 0.06% | +18.2% |
| Q3 2019 | $312,000 | +10.2% | 2,222 | +43.5% | 0.06% | +14.6% |
| Q2 2019 | $283,000 | -76.7% | 1,548 | -82.0% | 0.05% | -71.4% |
| Q3 2018 | $1,213,000 | +70.8% | 8,587 | +99.4% | 0.17% | +33.3% |
| Q4 2017 | $710,000 | +18.7% | 4,306 | -42.7% | 0.13% | +11.5% |
| Q2 2017 | $598,000 | +196.0% | 7,513 | +164.4% | 0.11% | +140.4% |
| Q1 2017 | $202,000 | – | 2,842 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
| Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
| EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
| New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
| AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
| APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
| OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
| Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |